RxDoctor Payments Data

Jacques Gaudet, MD

Otolaryngology · Thibodaux, LANPI 1750573994

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,220 of the $5,421 with a category attached, or 77.9%. 26 manufacturers reported payments, led by Aerin Medical Inc. at 37.3% of the total. Reporting peaked in 2019 at $1,754 and has fallen 51.7% since, to $847 in 2025.

$5,421in general payments, 2019–2025

Across 146 payments — averaging $37.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$2K
  • Acclarent, Inc$1K
  • Optinose US, Inc.$436
  • GSK$359
  • Stryker$249
  • Organogenesis Inc.$161
  • plus $1K from 20 others

What the payments were for

  • Travel & lodging$1,20122%
  • Food & beverage$4,22078%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,421 in reported general payments places this provider in the 85th percentile of 218 otolaryngology providers in Louisiana.

See all otolaryngology providers in Louisiana

Medicare billing

Part B allowed, 2024
$279,994
Medicare patients
759
Services billed
3,680

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine621$6,807
Azelastine Hcl267$6,676
Fluticasone Propionate383$5,126
Omeprazole197$2,279
Ofloxacin75$1,392
Ipratropium Bromide40$1,050
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav82$1,022
Methylprednisolone136$981
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen87$944
Mupirocin83$641
Levothyroxine Sodium81$557
Montelukast Sodium58$452
Levocetirizine Dihydrochloride27$432
Clindamycin Hcl33$347
Ciprofloxacin Hcl20$283

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Thibodaux

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →